S
RARE icon

Sachetta’s Ultragenyx Pharmaceutical RARE Stock Holding History

Sachetta’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$935 Buy
+28
New +$695 ﹤0.01% 895
2025
Q3 		– Sell
-86
Closed -$3.13K – 1124
2025
Q2 		$3.13K Buy
+86
New +$3.1K ﹤0.01% 700
2025
Q1 		– Sell
-32
Closed -$1.35K – 1189
2024
Q4 		$1.35K Hold
32
– – ﹤0.01% 924
2024
Q3 		$1.78K Hold
32
– – ﹤0.01% 910
2024
Q2 		$1.43K Hold
32
– – ﹤0.01% 948
2024
Q1 		$1.53K Hold
32
– – ﹤0.01% 797
2023
Q4 		$1.53K Buy
+32
New +$1.24K ﹤0.01% 797

Other funds holding RARE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

Sachetta's RARE Position: Q2 2026 in Review

Sachetta opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 28 shares worth $935. The stake represents ﹤0.01% of the portfolio and ranks #895 among its holdings. This is a return to the name: Sachetta previously reported a position in RARE as recently as Q2 2025.

Sachetta first reported a position in RARE in Q4 2023 and has held it in 7 quarters since. The position peaked at $3.13K in Q2 2025. 21 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Sachetta held 28 shares of Ultragenyx Pharmaceutical worth $935 as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new Sachetta position in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #895 holding.
  • Sachetta first reported a position in Ultragenyx Pharmaceutical in Q4 2023 and has held it in 7 quarters since.
  • Sachetta's Ultragenyx Pharmaceutical position peaked at $3.13K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.